Patent details
EP3210604 Title: USES OF DULOXETINE HCL MEDICAMENT IN PREPARING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER
Basic Information
- Publication number:
- EP3210604
- PCT Application Number:
- CN2015092782
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP158525576
- PCT Publication Number:
- WO2016062291
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USES OF DULOXETINE HCL MEDICAMENT IN PREPARING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER
- French Title of Invention:
- UTILISATIONS DU MÉDICAMENT DULOXÉTINE HCL DANS LA PRÉPARATION D'UNE COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- VERWENDUNGEN EINES DULOXETIN-HCL-MEDIKAMENTS BEI DER HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNG ZUR BEHANDLUNG VON KREBS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 14/02/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 21/02/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 14/02/2024
- Unitary Effect Registration Date:
- 21/02/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 23/10/2015
- Grant date:
- 14/02/2024
- EP Publication Date:
- 30/08/2017
- PCT Publication Date:
- 28/04/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/02/2024
- EP B1 Publication Date:
- 14/02/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/10/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/02/2024
- Name:
- Launxp Biomedical Co., Ltd.
- Address:
- No. 6, Keya Rd., Daya Dist., Taichung City 42881, Taiwan (TW)
Inventor
1
- Name:
- CHEN, Chiu-Hung
- Address:
- Taiwan (TW)
2
- Name:
- CHUANG, Show-Mei
- Address:
- Taiwan (TW)
3
- Name:
- HSIAO, Nai-Wan
- Address:
- Taiwan (TW)
4
- Name:
- WAY, Tzong-Der
- Address:
- Taiwan (TW)
Priority
- Priority Number:
- 201462068298 P
- Priority Date:
- 24/10/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/381; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202407
- Publication date:
- 14/02/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202412
- Publication date:
- 20/03/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202413
- Publication date:
- 27/03/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|